Format

Send to

Choose Destination
Antiviral Res. 2018 May;153:60-69. doi: 10.1016/j.antiviral.2018.02.001. Epub 2018 Feb 5.

2017 international meeting of the Global Virus Network.

Author information

1
Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
2
South African Medical Research Council, Cape Town, South Africa.
3
Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.
4
National Institute of Infectious Diseases, Tokyo, Japan.
5
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
6
Global Virus Network, Baltimore, MD, USA. Electronic address: emcsweegan@gvn.org.
7
Global Virus Network, Baltimore, MD, USA.
8
Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore.

Abstract

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. The 2017 meeting was held from September 25-27 in Melbourne, Australia, and was hosted by the Peter Doherty Institute for Infection and Immunity and the Institut Pasteur. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including the recent Zika epidemic, infections by human papillomavirus, influenza, HIV, hepatitis C, HTLV-1, and chikungunya viruses, and new and emerging viruses in the Australasia region. Plans for the 2018 meeting also are noted.

KEYWORDS:

Emerging viruses; Global virus network; International collaborations; Medical virology

PMID:
29421321
DOI:
10.1016/j.antiviral.2018.02.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center